Clinical Trials
20
Active:0
Completed:20
Trial Phases
3 Phases
Phase 3:9
Phase 4:4
Not Applicable:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
Phase 3
9 (47.4%)Not Applicable
6 (31.6%)Phase 4
4 (21.1%)A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.
Phase 3
Completed
- Conditions
- SchizophreniaSchizoaffective Disorder
- First Posted Date
- 2007-11-14
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Janssen, LP
- Target Recruit Count
- 811
- Registration Number
- NCT00558298
A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.
Phase 3
Completed
- Conditions
- SchizophreniaSchizoaffective Disorder
- First Posted Date
- 2007-07-02
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Janssen, LP
- Target Recruit Count
- 314
- Registration Number
- NCT00495118
A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.
Phase 4
Completed
- Conditions
- Schizoaffective DisorderSchizophrenia
- First Posted Date
- 2006-09-19
- Last Posted Date
- 2010-04-27
- Lead Sponsor
- Janssen, LP
- Target Recruit Count
- 120
- Registration Number
- NCT00378183
A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.
Phase 4
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2005-12-05
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Janssen, LP
- Target Recruit Count
- 650
- Registration Number
- NCT00261430
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia
Phase 3
Completed
- Conditions
- Dementia, VascularDementiaAlzheimer Disease
- First Posted Date
- 2005-11-15
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- Janssen, LP
- Target Recruit Count
- 626
- Registration Number
- NCT00253123
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found